866-997-4948(US-Canada Toll Free)

United States Branded Generics Market Report 2017

Published By :

QYResearch

Published Date : Mar 2017

Category :

Pharmaceutical

No. of Pages : 99 Pages

In this report, the United States Branded Generics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Branded Generics in these regions, from 2012 to 2022 (forecast).

United States Branded Generics market competition by top manufacturers/players, with Branded Generics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Mylan NV
Novartis AG
Eva Pharmaceutical Industries
Pfizer
Sun Pharmaceutical Industries
Aspen Pharmacare Holding
Abbott Laboratories
Valeant Pharmaceuticals International

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Alkylating Agents
Antimetabolites
Hormones
Anti-Hypertensive
Lipid Lowering Drugs
Anti-Depressants
Anti-Psychotics
Anti-Epileptics
Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Branded Generics for each application, including
Oral
Parenteral
Topical
Other

Table of Contents

United States Branded Generics Market Report 2017
1 Branded Generics Overview
1.1 Product Overview and Scope of Branded Generics
1.2 Classification of Branded Generics by Product Category
1.2.1 United States Branded Generics Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Branded Generics Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Alkylating Agents
1.2.4 Antimetabolites
1.2.5 Hormones
1.2.6 Anti-Hypertensive
1.2.7 Lipid Lowering Drugs
1.2.8 Anti-Depressants
1.2.9 Anti-Psychotics
1.2.10 Anti-Epileptics
1.2.11 Other
1.3 United States Branded Generics Market by Application/End Users
1.3.1 United States Branded Generics Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Oral
1.3.3 Parenteral
1.3.4 Topical
1.3.5 Other
1.4 United States Branded Generics Market by Region
1.4.1 United States Branded Generics Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Branded Generics Status and Prospect (2012-2022)
1.4.3 Southwest Branded Generics Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Branded Generics Status and Prospect (2012-2022)
1.4.5 New England Branded Generics Status and Prospect (2012-2022)
1.4.6 The South Branded Generics Status and Prospect (2012-2022)
1.4.7 The Midwest Branded Generics Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Branded Generics (2012-2022)
1.5.1 United States Branded Generics Sales and Growth Rate (2012-2022)
1.5.2 United States Branded Generics Revenue and Growth Rate (2012-2022)

2 United States Branded Generics Market Competition by Players/Suppliers
2.1 United States Branded Generics Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Branded Generics Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Branded Generics Average Price by Players/Suppliers (2012-2017)
2.4 United States Branded Generics Market Competitive Situation and Trends
2.4.1 United States Branded Generics Market Concentration Rate
2.4.2 United States Branded Generics Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Branded Generics Manufacturing Base Distribution, Sales Area, Product Type

3 United States Branded Generics Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Branded Generics Sales and Market Share by Region (2012-2017)
3.2 United States Branded Generics Revenue and Market Share by Region (2012-2017)
3.3 United States Branded Generics Price by Region (2012-2017)

4 United States Branded Generics Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Branded Generics Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Branded Generics Revenue and Market Share by Type (2012-2017)
4.3 United States Branded Generics Price by Type (2012-2017)
4.4 United States Branded Generics Sales Growth Rate by Type (2012-2017)

5 United States Branded Generics Sales (Volume) by Application (2012-2017)
5.1 United States Branded Generics Sales and Market Share by Application (2012-2017)
5.2 United States Branded Generics Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Branded Generics Players/Suppliers Profiles and Sales Data
6.1 Mylan NV
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Branded Generics Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Mylan NV Branded Generics Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Novartis AG
6.2.2 Branded Generics Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Novartis AG Branded Generics Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Eva Pharmaceutical Industries
6.3.2 Branded Generics Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Eva Pharmaceutical Industries Branded Generics Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Pfizer
6.4.2 Branded Generics Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Pfizer Branded Generics Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Sun Pharmaceutical Industries
6.5.2 Branded Generics Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Sun Pharmaceutical Industries Branded Generics Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Aspen Pharmacare Holding
6.6.2 Branded Generics Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Aspen Pharmacare Holding Branded Generics Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Abbott Laboratories
6.7.2 Branded Generics Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Abbott Laboratories Branded Generics Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Valeant Pharmaceuticals International
6.8.2 Branded Generics Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Valeant Pharmaceuticals International Branded Generics Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview

7 Branded Generics Manufacturing Cost Analysis
7.1 Branded Generics Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Branded Generics

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Branded Generics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Branded Generics Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Branded Generics Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Branded Generics Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Branded Generics Sales Volume Forecast by Type (2017-2022)
11.3 United States Branded Generics Sales Volume Forecast by Application (2017-2022)
11.4 United States Branded Generics Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Branded Generics
Figure United States Branded Generics Market Size (MT) by Type (2012-2022)
Figure United States Branded Generics Sales Volume Market Share by Type (Product Category) in 2016
Figure Alkylating Agents Product Picture
Figure Antimetabolites Product Picture
Figure Hormones Product Picture
Figure Anti-Hypertensive Product Picture
Figure Lipid Lowering Drugs Product Picture
Figure Anti-Depressants Product Picture
Figure Anti-Psychotics Product Picture
Figure Anti-Epileptics Product Picture
Figure Other Product Picture
Figure United States Branded Generics Market Size (MT) by Application (2012-2022)
Figure United States Sales Market Share of Branded Generics by Application in 2016
Figure Oral Examples
Figure Parenteral Examples
Figure Topical Examples
Figure Other Examples
Figure United States Branded Generics Market Size (Million USD) by Region (2012-2022)
Figure The West Branded Generics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Branded Generics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Branded Generics Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Branded Generics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Branded Generics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Branded Generics Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Branded Generics Sales (MT) and Growth Rate (2012-2022)
Figure United States Branded Generics Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Branded Generics Market Major Players Product Sales Volume (MT) (2012-2017)
Table United States Branded Generics Sales (MT) of Key Players/Suppliers (2012-2017)
Table United States Branded Generics Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Branded Generics Sales Share by Players/Suppliers
Figure 2017 United States Branded Generics Sales Share by Players/Suppliers
Figure United States Branded Generics Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Branded Generics Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Branded Generics Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Branded Generics Revenue Share by Players/Suppliers
Figure 2017 United States Branded Generics Revenue Share by Players/Suppliers
Table United States Market Branded Generics Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market Branded Generics Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States Branded Generics Market Share of Top 3 Players/Suppliers
Figure United States Branded Generics Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Branded Generics Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Branded Generics Product Category
Table United States Branded Generics Sales (MT) by Region (2012-2017)
Table United States Branded Generics Sales Share by Region (2012-2017)
Figure United States Branded Generics Sales Share by Region (2012-2017)
Figure United States Branded Generics Sales Market Share by Region in 2016
Table United States Branded Generics Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Branded Generics Revenue Share by Region (2012-2017)
Figure United States Branded Generics Revenue Market Share by Region (2012-2017)
Figure United States Branded Generics Revenue Market Share by Region in 2016
Table United States Branded Generics Price (USD/MT) by Region (2012-2017)
Table United States Branded Generics Sales (MT) by Type (2012-2017)
Table United States Branded Generics Sales Share by Type (2012-2017)
Figure United States Branded Generics Sales Share by Type (2012-2017)
Figure United States Branded Generics Sales Market Share by Type in 2016
Table United States Branded Generics Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Branded Generics Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Branded Generics by Type (2012-2017)
Figure Revenue Market Share of Branded Generics by Type in 2016
Table United States Branded Generics Price (USD/MT) by Types (2012-2017)
Figure United States Branded Generics Sales Growth Rate by Type (2012-2017)
Table United States Branded Generics Sales (MT) by Application (2012-2017)
Table United States Branded Generics Sales Market Share by Application (2012-2017)
Figure United States Branded Generics Sales Market Share by Application (2012-2017)
Figure United States Branded Generics Sales Market Share by Application in 2016
Table United States Branded Generics Sales Growth Rate by Application (2012-2017)
Figure United States Branded Generics Sales Growth Rate by Application (2012-2017)
Table Mylan NV Basic Information List
Table Mylan NV Branded Generics Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Mylan NV Branded Generics Sales Growth Rate (2012-2017)
Figure Mylan NV Branded Generics Sales Market Share in United States (2012-2017)
Figure Mylan NV Branded Generics Revenue Market Share in United States (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Branded Generics Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Novartis AG Branded Generics Sales Growth Rate (2012-2017)
Figure Novartis AG Branded Generics Sales Market Share in United States (2012-2017)
Figure Novartis AG Branded Generics Revenue Market Share in United States (2012-2017)
Table Eva Pharmaceutical Industries Basic Information List
Table Eva Pharmaceutical Industries Branded Generics Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Eva Pharmaceutical Industries Branded Generics Sales Growth Rate (2012-2017)
Figure Eva Pharmaceutical Industries Branded Generics Sales Market Share in United States (2012-2017)
Figure Eva Pharmaceutical Industries Branded Generics Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Branded Generics Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Branded Generics Sales Growth Rate (2012-2017)
Figure Pfizer Branded Generics Sales Market Share in United States (2012-2017)
Figure Pfizer Branded Generics Revenue Market Share in United States (2012-2017)
Table Sun Pharmaceutical Industries Basic Information List
Table Sun Pharmaceutical Industries Branded Generics Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sun Pharmaceutical Industries Branded Generics Sales Growth Rate (2012-2017)
Figure Sun Pharmaceutical Industries Branded Generics Sales Market Share in United States (2012-2017)
Figure Sun Pharmaceutical Industries Branded Generics Revenue Market Share in United States (2012-2017)
Table Aspen Pharmacare Holding Basic Information List
Table Aspen Pharmacare Holding Branded Generics Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Aspen Pharmacare Holding Branded Generics Sales Growth Rate (2012-2017)
Figure Aspen Pharmacare Holding Branded Generics Sales Market Share in United States (2012-2017)
Figure Aspen Pharmacare Holding Branded Generics Revenue Market Share in United States (2012-2017)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Branded Generics Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Abbott Laboratories Branded Generics Sales Growth Rate (2012-2017)
Figure Abbott Laboratories Branded Generics Sales Market Share in United States (2012-2017)
Figure Abbott Laboratories Branded Generics Revenue Market Share in United States (2012-2017)
Table Valeant Pharmaceuticals International Basic Information List
Table Valeant Pharmaceuticals International Branded Generics Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Valeant Pharmaceuticals International Branded Generics Sales Growth Rate (2012-2017)
Figure Valeant Pharmaceuticals International Branded Generics Sales Market Share in United States (2012-2017)
Figure Valeant Pharmaceuticals International Branded Generics Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Branded Generics
Figure Manufacturing Process Analysis of Branded Generics
Figure Branded Generics Industrial Chain Analysis
Table Raw Materials Sources of Branded Generics Major Players/Suppliers in 2016
Table Major Buyers of Branded Generics
Table Distributors/Traders List
Figure United States Branded Generics Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure United States Branded Generics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Branded Generics Price (USD/MT) Trend Forecast (2017-2022)
Table United States Branded Generics Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Branded Generics Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Branded Generics Sales Volume (MT) Forecast by Type in 2022
Table United States Branded Generics Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Branded Generics Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Branded Generics Sales Volume (MT) Forecast by Application in 2022
Table United States Branded Generics Sales Volume (MT) Forecast by Region (2017-2022)
Table United States Branded Generics Sales Volume Share Forecast by Region (2017-2022)
Figure United States Branded Generics Sales Volume Share Forecast by Region (2017-2022)
Figure United States Branded Generics Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *